Select Page

Lesotho

The first Lesotho Population-based HIV Impact Assessment (LePHIA) was conducted between November 2016 and May 2017 to measure the status of the national HIV response.

The survey team visited over 10,000 households, interviewed participants, and provided HIV counseling and testing.

In 2019, a second LePHIA 2020 survey was launched by the Ministry of Health to assess the country’s progress towards HIV epidemic control. The LePHIA 2020 survey conducted nearly 10,000 household interviews.

Details on the summary sheet findings can be found below.

LePHIA 2020: Key Findings*

%

Annual HIV incidence among adults

%

HIV prevalence among adults

%

Viral load suppression among adults living with HIV*

LePHIA 2020: 95-95-95 among adults living with HIV

50%

Adults living with HIV who knew their HIV status

75%

Adults who were aware of their HIV status who were on ART

75%

Adults who were on ART who had viral load suppression

*LePHIA 2016-2017 Summary Sheet and Final Report, as well as related reports and publications, can be found below.

Related Resources

No results found.
Recent PHIA News
Major HIV Assessment Launches in Zimbabwe
Major HIV Assessment Launches in Zimbabwe
September 29, 2015
On September 18th, the Zimbabwe Population-based HIV Impact Assessment (ZIMPHIA) was formally launched in Harare by Zimbabwe’s Ministry of Health and Child Care, the National AIDS Council, the Ambassador of the Government of the United States of America, and representatives of PEPFAR, CDC, ICAP at Columbia University, and other project partners.
ICAP to lead large population-based HIV surveys in 20 African countries
ICAP to lead large population-based HIV surveys in 20 African countries
October 21, 2014
ICAP at Columbia University has received $25 million in the first year of a $125 million, five-year award from the U.S. Centers for Disease Control and Prevention to conduct national, population-based HIV impact assessments (PHIAs) in 20 countries in sub-Saharan Africa.

This project is supported by the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention under the terms of cooperative agreement #U2GGH001226. The contents of this site are the responsibility of ICAP and do not necessarily reflect the views of the United States Government.  The mark “CDC” is owned by the US Dept. of Health and Human Services and is used with permission. Use of this logo is not an endorsement by HHS or CDC of any particular product, service, or enterprise.

 

ICAP at Columbia University, 722 West 168th Street, New York, NY 10032
ICAP • CONTACT • PRIVACY POLICY